8.07 USD
▲-0.01+2.67%
盘后 7.86 0.00%
2026-08-03
市值
$7.03B
市盈率
13.61
EPS
0.75
股息率
1.09%
52 周区间
6.96 – 10.88
成交量
632.92K
Beta
1.18
目标价
10.87
52W 低 6.9652W 高 10.88
价格走势
公司简介
Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as wel...